HeartFlow Analysis Demonstrates Highest Diagnostic Performance for Detecting Heart Disease Compared to Other Non-Invasive Tests
Two New Studies Reinforce Value of the HeartFlow Analysis in Providing Functional Evaluation of Coronary Blockages and Enabling Clinicians to Make Treatment Decisions Paris, France – May 22, 2018 – HeartFlow, Inc. today announced new data from the PACIFIC trial showed that the HeartFlow Analysis had the highest diagnostic performance for detecting coronary artery disease (CAD), the most […]
NHS England to Provide Innovation and Technology Payment (ITP) to Drive Adoption of HeartFlow Analysis in the United Kingdom
HeartFlow Analysis recognized as proven innovation to deliver efficiency and improve quality in healthcare REDWOOD CITY, Calif. – April 10, 2018 – HeartFlow, Inc. today announced that NHS England has chosen the HeartFlow FFRCT Analysis as part of the Innovation and Technology Payment (ITP) program. The HeartFlow Analysis was chosen as a new technology to be funded by ITP through […]
HeartFlow Announces Collaborative Research Agreement with Imperial College London
Joint research in medical imaging and deep learning to help improve treatment planning for patients with heart disease REDWOOD CITY, Calif. – March 7, 2018 – HeartFlow, Inc. today announced that it has entered into a collaborative research agreement with Imperial College London. The collaboration will enable experts from HeartFlow and Imperial to work side-by-side on joint projects […]
HeartFlow Enters into Licensing Agreement with Cedars-Sinai for Coronary Plaque Assessment Technology
AutoPlaque Technology Will Accelerate HeartFlow’s Efforts to Bring Plaque Assessment to the HeartFlow Analysis REDWOOD CITY, Calif. – March 1, 2018 – HeartFlow, Inc. today announced that it has entered into a licensing and technology transfer agreement with Cedars-Sinai in Los Angeles for AutoPlaque technology, a software tool used to detect and characterize coronary artery plaque based on […]
HeartFlow Announces Decision by Centers for Medicare & Medicaid Services to Assign a New Technology Payment Classification to HeartFlow® FFRCT Analysis
CMS assigns hospital payment amount for non-invasive technology to aid diagnosis of suspected coronary artery disease REDWOOD CITY, Calif. – November 6, 2017 – HeartFlow Inc. today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment Classification (APC) for the HeartFlow® FFRCT Analysis, a first-of-its-kind non-invasive technology that helps clinicians diagnose […]
HeartFlow Names Former J&J Chairman and CEO William C. Weldon Chairman of the Board
REDWOOD CITY, Calif. – June 21, 2017 – HeartFlow, Inc. today announced that William C. Weldon, a board member of the Company since December 2014, has been appointed to chairman. This will enable chairman and chief executive officer John H. Stevens, M.D., to focus on leading HeartFlow into its next stage of growth. Dr. Stevens will continue to […]
Siemens Healthineers and HeartFlow® Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs
Global agreement allows companies to develop integrated, noninvasive care solutions for improved management of coronary artery disease patients; the collaboration’s joint solution pairs CT scanners from Siemens Healthineers with the HeartFlow FFRCT Analysis ERLANGEN, Germany and REDWOOD CITY, Calif. USA – March 16, 2017 – Siemens Healthineers and HeartFlow, Inc. have entered into a global collaboration agreement to provide a […]
NICE Guidance Recommends HeartFlow FFRCT Analysis to Help Determine Cause of Stable Chest Pain in Patients
REDWOOD CITY, Calif. – Feb. 13, 2017 – The National Institute for Health and Care Excellence (NICE) in the United Kingdom issued guidance today for use of the HeartFlow® FFRCT Analysis to help determine the cause of stable chest pain in patients. Developed by HeartFlow, Inc., the HeartFlow FFRCT Analysis is the first non-invasive technology to provide insight into […]
HeartFlow FFRCT Analysis Receives Regulatory Approval in Japan
REDWOOD CITY, Calif. – Nov. 17, 2016 – HeartFlow Inc. has announced the approval of its HeartFlow® FFRCT Analysis by the Japanese Ministry of Health, Labour and Welfare (MHLW). The HeartFlow FFRCT Analysis is the only non-invasive technology to deliver insights on both the extent of a coronary blockage and any impact the blockage has on blood flow to the […]
Providence Health Care Becomes First Canadian Center to Adopt Revolutionary HeartFlow FFRCT Analysis to Assess Coronary Artery Disease
REDWOOD CITY, Calif. – July 21, 2016 – Providence Health Care has become the first center in Canada to adopt the HeartFlow® FFRCT Analysis, and also first in the world to utilize the next generation version of the platform. The HeartFlow FFRCT Analysis, which was recently approved by Health Canada, is a novel, non-invasive technology used by clinicians to assess […]
